Cochrane Abstracts
Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rapid Versus Standard Antimicrobial Susceptibility Testing to Guide Treatment of Bloodstream Infection." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439839/all/Convalescent_plasma_and_hyperimmune_immunoglobulin_to_prevent_infection_with_SARS‐CoV‐2_New. Accessed 19 April 2024.
Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439839/all/Convalescent_plasma_and_hyperimmune_immunoglobulin_to_prevent_infection_with_SARS‐CoV‐2_New. Accessed April 19, 2024.
Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439839/all/Convalescent_plasma_and_hyperimmune_immunoglobulin_to_prevent_infection_with_SARS‐CoV‐2_New
Rapid Versus Standard Antimicrobial Susceptibility Testing to Guide Treatment of Bloodstream Infection [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439839/all/Convalescent_plasma_and_hyperimmune_immunoglobulin_to_prevent_infection_with_SARS‐CoV‐2_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection
ID - 439839
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439839/all/Convalescent_plasma_and_hyperimmune_immunoglobulin_to_prevent_infection_with_SARS‐CoV‐2_New
DB - Evidence Central
DP - Unbound Medicine
ER -
